Gene therapy that inhibits NF-κB results in apoptosis of human hepatocarcinoma by recombinant adenovirus

doi:10.3748/wjg.v12.i33.5287

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 33

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2303)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

268

HTML

1909

Figures (1-5)

126

Sum=2303

Sep 7, 2006 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Sep 7, 2006; 12(33): 5287-5292
Published online Sep 7, 2006. doi: 10.3748/wjg.v12.i33.5287

Full Size Figure Download Figure

Figure 3 Morphological changes of HepG₂ cells from mice treated with different methods were analyzed by HE staining. A: PBS control; B: AdIκBαM (2 × 10¹⁰); C: AdIκBαM (2 × 10¹¹); D: AdIκBαM (2 × 10¹²); E: AdIκBα (2 × 10¹²).

Citation: Li TJ, Jia LP, Gao XL, Huang AL. Gene therapy that inhibits NF-κB results in apoptosis of human hepatocarcinoma by recombinant adenovirus. World J Gastroenterol 2006; 12(33): 5287-5292
URL: https://www.wjgnet.com/1007-9327/full/v12/i33/5287.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i33.5287